Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness Study of Deferoxamine and Xingnaojing Injection in Intracerebral Hemorrhage

NCT02367248 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT02367248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02367248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness Study of Deferoxamine and Xingnaojing Injection in Intracerebral Hemorrhage
Lead sponsor
Capital Medical University
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 31, 2015
Completion date
December 31, 2016
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral hemorrhage